Correspondence 0001104659-24-054011 from Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc.
Date: April 29, 2024 · CIK: 0001585608 · Accession: 0001104659-24-054011
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278861
Letter
Re: Jaguar Health, Inc.
April 29, 2024
Via EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-3
File No. 333-278861
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission on Wednesday, May 1, 2024, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant hereby authorizes each of Donald C. Reinke, Esq. and Michael S. Lee, Esq. of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration.
Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358.
Very truly yours,
Jaguar Health, Inc.
Show Raw Text
CORRESP
1
filename1.htm
April 29, 2024
Via EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Jaguar Health, Inc.
Registration Statement on Form S-3
File No. 333-278861
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities
Act of 1933, as amended, Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced
Registration Statement on Form S-3 (the “Registration Statement”) be declared effective by the Securities and Exchange
Commission on Wednesday, May 1, 2024, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant hereby authorizes
each of Donald C. Reinke, Esq. and Michael S. Lee, Esq. of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw
this request for acceleration.
Please confirm effectiveness by advising our counsel,
Michael S. Lee of Reed Smith LLP, at (212) 549-0358.
Very truly yours,
Jaguar Health, Inc.
/s/ Lisa A. Conte
Lisa A. Conte
Chief Executive Officer and President
Jaguar Health, Inc. ·
200 Pine Street, Suite 400 · San Francisco, CA 94104
Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311
· https://jaguar.health